Exposure to antipsychotics and risk of stroke: self controlled case series study
- PMID: 18755769
- PMCID: PMC2526549
- DOI: 10.1136/bmj.a1227
Exposure to antipsychotics and risk of stroke: self controlled case series study
Abstract
Objectives: To investigate the association between use of typical and atypical antipsychotic drugs and incidence of stroke in patients with and without dementia.
Design: Self controlled case series.
Setting: UK based electronic primary care records in the general practice research database (GPRD).
Participants: All patients registered in the database with a recorded incident stroke and at least one prescription for any antipsychotic drug before the end of 2002: 6790 eligible participants were identified and included in the final analysis.
Main outcome measures: Rate ratio for stroke in periods of time exposed to antipsychotics compared with unexposed periods.
Results: Use of any antipsychotic drug was associated with a rate ratio for stroke of 1.73 (95% confidence interval 1.60 to 1.87): 1.69 (1.55 to 1.84) for typical antipsychotics and 2.32 (1.73 to 3.10) for atypical antipsychotics. In patients receiving any antipsychotic drug, the rate ratios were 3.50 (2.97 to 4.12) for those with dementia and 1.41 (1.29 to 1.55) for those without dementia.
Conclusions: All antipsychotics are associated with an increased risk of stroke, and the risk might be higher in patients receiving atypical antipsychotics than those receiving typical antipsychotics. People with dementia seem to be at a higher risk of an associated stroke than people without dementia and use of antipsychotics should, when possible, be avoided in these patients.
Conflict of interest statement
Competing interests: None declared.
Figures
Comment in
-
The self controlled case series method.BMJ. 2008 Aug 28;337:a1069. doi: 10.1136/bmj.a1069. BMJ. 2008. PMID: 18755768 No abstract available.
-
Antipsychotics and stroke risk. Madness of modern medicine.BMJ. 2008 Sep 16;337:a1670. doi: 10.1136/bmj.a1670. BMJ. 2008. PMID: 18796484 No abstract available.
-
Effect of antipsychotics on stroke risk remains unproved.BMJ. 2008 Sep 16;337:a1673. doi: 10.1136/bmj.a1673. BMJ. 2008. PMID: 18796486 No abstract available.
References
-
- Health Canada. Important drug safety information: RISPERDAL* (risperidone) and cerebrovascular adverse events in placebo-controlled dementia trials. Toronto: Janssen-Ortho, 2002. http://hc-sc.gc.ca/dhp-mps/medeff/advisories-avis/prof/2002/risperdal_hp....
-
- Committee on Safety of Medicines. Atypical antipsychotic drugs and stroke: message from Professor Gordon Duff, chairman, (CEM/CMO/2004/1). London: Committee on Safety of Medicines, 2006.
-
- Herrmann N, Mamdani M, Lanctot KL. Atypical antipsychotics and risk of cerebrovascular accidents. Am J Psychiatry 2004;161:1113-5. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical